In particular, deep tech startups promote scientific and technological breakthroughs to build a better world through deep technologies such as big data and AI.
Developing medical devices and medicines is not easy. Startups born in laboratories have to transfer their technologies, carry out processes such as clinical trials to test them and obtain specific certificates that extend the market launch period.
Esther Rodríguez Villegas, professor at Imperial College London and co-founder of the startup Acurable, which develops medical devices for the diagnosis of obstructive sleep apnea, shares her entrepreneurial experience in the deep tech field in this second episode of 'Constante Futuro', the innovation podcast by Mapfre and MIT Marketing Review in Spanish, hosted by Carlos Corominas, Editor-in-Chief of MIT Technology Review in spanish, together with Cristina Sánchez.
In addition, this episode also features the vision of Daniel Oliver, director of the investment platform specialized in life sciences Capital Cell and partner at Nara Capital, a fund focused on healthtech, who portrays the current landscape of innovation in health technologies and shares the keys to the healthcare of the future.
Esther Rodriguez Villegas is professor in Low Power Electronic Engineering at Imperial College London, Fellow of the Royal Academy of Engineering, director of the Wearable Technologies Lab and founder of the company Acurable, created in 2016, by which she diagnoses obstructive sleep apnea through algorithms and commercializes advanced wearable devices to diagnose and accurately monitor respiratory conditions. From her area of expertise, low power electronics, the professor has driven the development of portable sensors for physiological monitoring with a focus on healthcare applications.
Oliver as co-founder and CEO of Rejuvenate Bio, also talks about his experience as an entrepreneur in the healthcare field and discusses innovation and financing in deep tech in healthcare.